Provides a sales and use tax exemption on digital breast tomosynthesis and for labor and services rendered in respect to installing, repairing, cleaning, altering, or improving digital breast tomosynthesis.

Requires the administrator of the state health care authority to select the health technology digital breast tomosynthesis for review by the health technology clinical committee by July 1, 2024.

Requires the review to include information on the efficacy and cost-effectiveness of digital breast tomosynthesis as a means of breast cancer screening.

Expires July 1, 2016.